NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report

NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report

Show other versions (1)

Background: NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efficacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants are hetero...

Full description

Bibliographic Details
Main Authors: Baharin, J (Author), Basri, H (Author), Hanapiah, FA (Author), Hoo, FK (Author), Ibrahim, A (Author), Khan, AHKY (Author), Loh, WC (Author), Mat, LNI (Author), Noh, MSFM (Author), Rashid, AMA (Author), Sulaiman, WAW (Author)
Format: Article
Language:English
Published: 2021
Subjects:
BRAIN
Chinese traditional medication
EFFICACY
Elderly
Hepatotoxicity
INFARCT
MLC601 NEUROAID(R)
NeuroAid II
PROFILE
RECOVERY
SAFETY
Stroke
TRADITIONAL CHINESE MEDICINE
WARFARIN
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items